Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000227627 | SCV000283948 | benign | Gastrointestinal stromal tumor | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001026319 | SCV001188678 | likely benign | Hereditary cancer-predisposing syndrome | 2019-09-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV003159114 | SCV003852904 | likely benign | not provided | 2023-03-28 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
KCCC/NGS Laboratory, |
RCV000227627 | SCV004015805 | benign | Gastrointestinal stromal tumor | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003955300 | SCV004769100 | likely benign | KIT-related disorder | 2022-12-09 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |